Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Scientific Reports|November 26, 2025
Gestational hypothyroxinemia causes an inflammatory environment at maternal-fetal tissues and fetal brain with impaired hippocampal dendritic spine maturation in the offspringEnrique González-Madrid, Ma Andreina Rangel-Ramírez, María C Opazo, et al.
Cancer Medicine|August 28, 2024
On the informative value of community-based indoor radon values in relation to lung cancerAlbert Rosenberger, Heike Bickeböller, David C Christiani, et al.
Frontiers in Immunology|July 26, 2021
IL-10-Dependent Amelioration of Chronic Inflammatory Disease by Microdose Subcutaneous Delivery of a Prototypic Immunoregulatory Small MoleculeJorge H Tabares-Guevara, Julio C Jaramillo, Laura Ospina-Quintero, et al.
Iscience|May 9, 2025
HSV-1 alters lipid metabolism and induces lipid droplet accumulation in functionally impaired mouse dendritic cellsMónica A Farías, Felipe A Cancino, Areli J Navarro, et al.
Cancer Medicine|November 21, 2019
A community-based lung cancer rapid tissue donation protocol provides high-quality drug-resistant specimens for proteogenomic analysesTheresa A Boyle, Gwendolyn P Quinn, Matthew B Schabath, et al.
Frontiers in Immunology|October 18, 2021
Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 VaccineLuisa F Duarte, Nicolás M S Gálvez, Carolina Iturriaga, et al.
Frontiers in Immunology|December 3, 2021
Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated VaccineFelipe Melo-González, Jorge A Soto, Liliana A González, et al.
Medrxiv : the Preprint Server for Health Sciences|April 20, 2022
A booster dose of an inactivated SARS-CoV-2 vaccine increases neutralizing antibodies and T cells that recognize Delta and Omicron variants of concernBárbara M Schultz, Felipe Melo-González, Luisa F Duarte, et al.
Iscience|August 18, 2025
Age and primary vaccination schedule impact humoral and cellular immunity with an inactivated SARS-CoV-2 vaccineYohana Martínez-Balboa, Linmar Rodríguez-Guilarte, Constanza Méndez, et al.
Elife|October 13, 2022
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trialNicolás M S Gálvez, Gaspar A Pacheco, Bárbara M Schultz, et al.
Pageof 4